tokens: OBJECTIVES : The United Kingdom Parkinson's Disease Research Group ( UKPDRG ) trial found an increased mortality in patients with Parkinson's disease ( PD ) randomized to receive 10 mg selegiline per day and L-dopa compared with those taking L-dopa alone .